Diagnosing REM sleep behavior disorder in Parkinson's disease without a gold standard: a latent-class model study.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
13 07 2020
Historique:
received: 11 06 2019
revised: 21 12 2019
pubmed: 5 4 2020
medline: 15 4 2021
entrez: 5 4 2020
Statut: ppublish

Résumé

To ascertain whether current diagnostic criteria for REM sleep behavior disorder (RBD) are appropriate in patients with Parkinson's disease (PD) consulting a movement disorder center, to evaluate the accuracy of REM sleep without atonia (RSWA) thresholds and determine the value of screening questionnaires to discriminate PD patients with RBD. One hundred twenty-eight consecutive PD patients (M = 80; mean age: 65.6 ± 8.3 years) underwent screening questionnaires, followed by a sleep-focused interview and a full-night video-polysomnography (vPSG). Without a gold standard, latent class models (LCMs) were applied to create an unobserved ("latent") variable. Sensitivity analysis was performed using RSWA cutoff derived from two visual scoring methods. Finally, we assessed the respective diagnostic performance of each diagnostic criterion for RBD and of the screening questionnaires. According to the best LCM-derived model, patients having either "history" or "video" with RSWA or alternatively showing both "history" and "video" without RSWA were classified as having RBD. Using both SINBAR and Montreal scoring methods, RSWA criterion showed the highest sensitivity while concomitant history of RBD and vPSG-documented behaviors, regardless to presence of RSWA, displayed the highest specificity. Currently recommended diagnostic threshold of RSWA was found to be optimal in our large cohort of PD patients. Both the RBD screening questionnaire (RBDSQ) and the RBD single question (RBD1Q) showed poor sensitivity and specificity. Results of the best LCM for diagnosis of RBD in PD were consistent with the current diagnostic criteria. Moreover, RBD might be considered in those PD patients with both history and vPSG-documented dream enactment behaviors, but with RSWA values within the normal range.

Identifiants

pubmed: 32246718
pii: 5815830
doi: 10.1093/sleep/zsz323
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Michela Figorilli (M)

EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France.
Sleep Disorder Center, Department of Public Health and Clinical and Molecular Medicine, University of Cagliari, Italy.

Ana R Marques (AR)

EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France.
Neurology Department, CHU Clermont-Ferrand, France.

Mario Meloni (M)

Sleep Disorder Center, Department of Public Health and Clinical and Molecular Medicine, University of Cagliari, Italy.

Maurizio Zibetti (M)

Department of Neuroscience, University of Turin, Italy.

Bruno Pereira (B)

Biostatistics Unit (DRCI), Clermont-Ferrand, France.

Celine Lambert (C)

Biostatistics Unit (DRCI), Clermont-Ferrand, France.

Monica Puligheddu (M)

Sleep Disorder Center, Department of Public Health and Clinical and Molecular Medicine, University of Cagliari, Italy.

Alessandro Cicolin (A)

Sleep Disorder Center, Department of Neuroscience, University of Turin, Italy.

Leonardo Lopiano (L)

Department of Neuroscience, University of Turin, Italy.

Franck Durif (F)

EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France.
Neurology Department, CHU Clermont-Ferrand, France.

Maria L Fantini (ML)

EA 7280, UFR Medicine, University of Clermont Auvergne, Clermont-Ferrand, France.
Neurology Department, CHU Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH